Compare FATE & SIEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FATE | SIEB |
|---|---|---|
| Founded | 2007 | 1886 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.6M | 164.1M |
| IPO Year | 2013 | 1996 |
| Metric | FATE | SIEB |
|---|---|---|
| Price | $1.13 | $2.08 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $4.10 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 41.4K |
| Earning Date | 05-29-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 29.88 | ★ 57.14 |
| EPS | N/A | ★ 0.14 |
| Revenue | $6,646,000.00 | ★ $83,901,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.05 | N/A |
| P/E Ratio | ★ N/A | $14.43 |
| Revenue Growth | N/A | ★ 17.32 |
| 52 Week Low | $0.66 | $1.77 |
| 52 Week High | $1.94 | $5.53 |
| Indicator | FATE | SIEB |
|---|---|---|
| Relative Strength Index (RSI) | 39.70 | 42.12 |
| Support Level | $0.96 | N/A |
| Resistance Level | $1.16 | $3.26 |
| Average True Range (ATR) | 0.13 | 0.12 |
| MACD | -0.04 | 0.05 |
| Stochastic Oscillator | 4.27 | 93.05 |
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
Siebert Financial Corp is a diversified financial services firm and provides a full range of brokerage and financial advisory services including securities brokerage, investment advisory and insurance offerings, and corporate stock plan administration solutions. The firm mainly provides online and traditional brokerage and related services to retail investors and also acts as an investment advisor for its subsidiary. The company operates in the securities brokerage and asset management industry. It also engages in Insurance services, Robo-advisory technology, and Prime brokerage business through its subsidiaries.